- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

2 new investors on the share capital increase in a proportion of 49 percent on Pace Project One Co., Ltd and 48.7 percent on Pace Project Three Co., Ltd. The Company remeasured the remaining

price: the average selling price of HRC in 1st Quarter of 2018 was THB 20,942/ton, increased by 12% as compared with last year quarter (THB 18,695/ton) according to HRC market price worldwide trend. - HRC

of HRC in 2nd Quarter of 2018 was THB 20,702/ton, increased by 19% as compared with last year quarter (THB 17,403/ton) according to HRC market price worldwide trend. - HRC cash margin (excluding

share with the total value of THB 195,000,000 with 23.1 percent discount which is discount more than 10 percent of the Market Price; therefore, it is considered as an offer of newly issued share at a

million, compared with QoQ. Earnings per share presented at Baht 0.31. In the six-month period of 2017, the Company reported consolidated revenues of Baht 1,014.4 million, increased by 22.3% compared with

36.3% According to the public relation and road show activities expense for initial public offering in the stock exchange market. Total selling and administrative expenses 14.8 16.2 9.5% Finance cost The

last year due to long term loan and working capital. (8) Share of profit (loss) from investment in associated company and joint ventures In 2018, the Company recognized the profit sharing from Mctric

Market for Alternative Investment (MAI) of the Company such as audit fees and financial advisor, etc. Net profit Net profit was 26.16 million baht in 2017 and 13.93 million baht in 2018, or equivalent to

and interest Objectives To be used for working capital (4) Nature of relationship The Company holds 70% of the share in the Company’s subsidiary, KT Medical Service Company Limited and the details of